Diagnostik und Therapie seminomatöser Hodentumoren

This publication has 33 references indexed in Scilit:

• Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
  Annals of Oncology, 2012
• Randomized Phase III Study Comparing Paclitaxel–Bleomycin, Etoposide, and Cisplatin (BEP) to Standard BEP in Intermediate-Prognosis Germ-Cell Cancer: Intergroup Study EORTC 30983
  Journal of Clinical Oncology, 2012
• Long‐term oncological outcome after post‐chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour
  BJU International, 2010
• Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial
  JNCI: Journal of the National Cancer Institute, 2010
• Quality of Surveillance for Stage I Testis Cancer in the Community
  Journal of Clinical Oncology, 2009
• European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
  European Urology, 2008
• European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II
  European Urology, 2008
• The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis
  Annals of Oncology, 2007
• Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
  JNCI: Journal of the National Cancer Institute, 2005
• Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients
  European Journal of Cancer, 1997